Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue and Ozone in Early Sepsis
NCT02910765Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Oct 2016
- Primary completion
- Mar 2017
- Modality
- Inhalation Devices, Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in sepsis comparing Methylene Blue + Ozone with Placebo (2 arms). Primary endpoint: Acute Physiology and Chronic Health Evaluation Score at 7 days. Status: unknown.
02
Drugs
methylene bluemedical ozonated water
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02910765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02910765.